ArticleFrontiers in immunology2023

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.

Oliver Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.